NASDAQ: INM
Inmed Pharmaceuticals Inc Stock Ownership - Who owns Inmed Pharmaceuticals?

Insider buying vs selling

Have Inmed Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Alexandra Diane Janet ManciniInsider2024-07-31240$0.18
$42.24Sell

1 of 1

INM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when INM insiders and whales buy or sell their stock.

INM Shareholders

What type of owners hold Inmed Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Shane Aaron Johnson48.30%583,023$1.60MInsider
Eric A. Adams3.64%43,959$120.89kInsider
Andrew Hull3.17%38,258$105.21kInsider
Bruce Colwill0.95%11,515$31.67kInsider
Ubs Group Ag0.51%6,106$16.79kInstitution
Sbi Securities Co Ltd0.02%300$825.00Institution
Banque Cantonale Vaudoise0.00%6$16.50Institution
Allsquare Wealth Management LLC0.00%1$2.75Institution
Federation Des Caisses Desjardins Du Quebec0.00%1$2.75Institution
Concourse Financial Group Securities Inc0.00%0$0.00Institution

1 of 2

INM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INM0.53%56.06%Net Selling
AZTR3.24%96.39%
EVAX1.93%0.00%
GRI0.18%99.82%
SPRC13.28%0.00%

Inmed Pharmaceuticals Stock Ownership FAQ

Who owns Inmed Pharmaceuticals?

Inmed Pharmaceuticals (NASDAQ: INM) is owned by 0.53% institutional shareholders, 56.06% Inmed Pharmaceuticals insiders, and 43.41% retail investors. Shane Aaron Johnson is the largest individual Inmed Pharmaceuticals shareholder, owning 583,023.00 shares representing 48.30% of the company. Shane Aaron Johnson's Inmed Pharmaceuticals shares are currently valued at $1.85M.

If you're new to stock investing, here's how to buy Inmed Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.